Portage Biotech Inc. (PRTG)

Portage Biotech Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	1.76	5.03	10.55	23.35	2.77	3.15
Short-Term Investments	-	-	-	-	-	0.07
Cash & Short-Term Investments	1.76	5.03	10.55	23.35	2.77	3.22
Cash Growth	-48.80%	-52.32%	-54.84%	743.03%	-13.98%	-48.64%
Other Receivables	0.57	0.04	0.24	0.21	0.68	0.56
Receivables	0.57	0.04	0.68	0.21	0.68	0.56
Prepaid Expenses	0.28	2.56	2.33	1.13	1.49	0.01
Other Current Assets	0.08	0.06	0.12	0.14	-	-
Total Current Assets	2.69	7.7	13.68	24.83	4.95	3.79
Property, Plant & Equipment	0.02	0.04	-	-	-	-
Long-Term Investments	-	-	2.89	9.08	9.14	8.63
Goodwill	-	-	-	43.32	43.32	43.32
Long-Term Deferred Charges	-	-	82.52	117.39	117.39	117.39
Other Long-Term Assets	-	0.05	0.04	0.04	0.06	0.03
Total Assets	2.71	7.78	99.13	194.66	174.86	173.17
Accounts Payable	0.22	0.48	0.27	0.19	0.11	0.34
Accrued Expenses	0.59	2.31	1.56	0.52	1.79	0.7
Short-Term Debt	-	-	-	-	-	1
Current Portion of Long-Term Debt	-	-	-	-	0.15	0.3
Current Portion of Leases	0.03	0.04	-	-	-	-
Other Current Liabilities	0.04	0.05	0.03	0.07	1.15	0.22
Total Current Liabilities	0.87	2.88	1.87	0.78	3.21	2.57
Long-Term Debt	-	-	-	-	-	3.36
Long-Term Leases	-	0.01	-	-	-	-
Long-Term Deferred Tax Liabilities	-	-	10.56	28.45	24.05	21.6
Other Long-Term Liabilities	1.14	1.56	11.31	-	-	-
Total Liabilities	2.01	4.45	23.73	29.23	27.26	27.53
Common Stock	219.61	219.5	218.78	158.32	130.65	117.82
Retained Earnings	-242.33	-239.32	-159.62	-55.01	-38.14	-22.3
Comprehensive Income & Other	24.13	23.84	16.88	17.89	8.94	1.02
Total Common Equity	1.4	4.02	76.05	121.21	101.45	96.53
Minority Interest	-0.7	-0.69	-0.65	44.23	46.15	49.11
Shareholders' Equity	0.7	3.33	75.4	165.43	147.6	145.64
Total Liabilities & Equity	2.71	7.78	99.13	194.66	174.86	173.17
Total Debt	0.03	0.05	-	-	0.15	4.66
Net Cash (Debt)	1.74	4.98	10.55	23.35	2.62	-1.44
Net Cash Growth	-45.05%	-52.76%	-54.84%	791.30%	-	-
Net Cash Per Share	1.65	5.15	13.08	35.76	4.47	-2.63
Filing Date Shares Outstanding	1.12	1.05	0.89	0.85	0.67	0.59
Total Common Shares Outstanding	1.12	0.99	0.88	0.67	0.6	0.55
Working Capital	1.81	4.82	11.81	24.05	1.74	1.23
Book Value Per Share	1.25	4.07	86.39	181.59	167.91	175.71
Tangible Book Value	1.4	4.02	76.05	77.88	58.13	53.21
Tangible Book Value Per Share	1.25	4.07	86.39	116.68	96.21	96.85

Source: S&P Capital IQ. Standard template. Financial Sources.